Sign in
4

Changes in Ownership

Olema Oncology, Inc. Filed Acc 0001336504-25-000009

Director sold 264,800 shares at an average $29.73 ($7,873,109)

  • Director acquired 264,800 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CLARK IAN T Director 2025-12-19 Option exercise +209,690 $4.41 $923,894 209,690 D
CLARK IAN T Director 2025-12-19 Option exercise +21,520 $3.61 $77,687 231,210 D
CLARK IAN T Director 2025-12-19 Option exercise +21,520 $7.84 $168,717 252,730 D
CLARK IAN T Director 2025-12-19 Option exercise +12,070 $4.08 $49,246 264,800 D
CLARK IAN T Director 2025-12-19 Sale −29,904 $28.83 $862,132 234,896 D
CLARK IAN T Director 2025-12-19 Sale −193,056 $29.71 $5,735,694 41,840 D
CLARK IAN T Director 2025-12-19 Sale −41,840 $30.48 $1,275,283 0 D
Derivatives
CLARK IAN T Director 2025-12-19 Option exercise · Stock Option (Right to Buy) −209,690 0 D
CLARK IAN T Director 2025-12-19 Option exercise · Stock Option (Right to Buy) −21,520 0 D
CLARK IAN T Director 2025-12-19 Option exercise · Stock Option (Right to Buy) −21,520 0 D
CLARK IAN T Director 2025-12-19 Option exercise · Stock Option (Right to Buy) −12,070 12,080 D
Open-market sales · 264,800 sh · avg $29.73 · $7,873,109
Loading xslF345X05/form4-12242025_021230.xml…